T-cells coordinate the immune response. Appropriate immunity is essential for effective host responses to respiratory pathogens such as influenza virus and Mycobacterium tuberculosis. T-cell immunodeficiency in advanced HIV disease confers susceptibility to opportunistic infections such as pneumocystiis carinii and Mycobacterium avium. Excessive lung inflammation in response to influenza virus can produce adult respiratory distress syndrome and respiratory failure. Activation of T-cells induces the production of T-cell growth and survival factor, IL-2. Regulatory T-cells intrinsically fail to induce IL-2 expression upon activation and can suppress IL-2 production in conventional T-cells. Thus, the control of IL-2 expression is critically important to T-cell immune responses, yet the mechanisms remain incompletely understood. T-cell activation triggered through antigen and CD28 receptors induces epigenetic modifications of histones including acetylation and methylation, DMA demethylation, nucleosome disruption, concerted binding of transcription factors to the IL-2 proximal promoter and IL-2 transcription. NF90 is a zinc finger DNA- and double-stranded RNA binding protein subunit that binds specifically and inducibly to the antigen receptor response element/NF-AT target sequence in the IL-2 proximal promoter, as shown by chromatin immunoprecipitation. NF90 possesses intrinsic histone acetyltransferase (HAT) activity. The hypothesis to be tested is that epigenetic modifications of histones at the IL-2 promoter that regulate chromatin remodeling and transcriptional activation involve the HAT activity of NF90. The hypothesis will be tested that FoxP3 expression in regulatory T-cells interferes with epigenetic modifications that regulate IL-2 chromatin remodeling and transcriptional activation.
The aims are to: 1) Characterize epigenetic modifications of histones, DNA and transcription factors associated with IL-2 chromatin remodeling during T-cell activation, 2) Characterize the role of NF90 HAT activity in IL-2 activation, 3) Characterize how FoxP3 regulates epigenetic modifications and chromatin remodeling at the IL-2 proximal promoter and other promoters. Further molecular insights into the regulation of IL-2 gene expression in activated T-cells will identify novel targets and strategies for therapeutic manipulation of T-cell immune responses in disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI039624-15
Application #
8081863
Study Section
Lung Cellular, Molecular, and Immunobiology Study Section (LCMI)
Program Officer
Dong, Gang
Project Start
1996-04-01
Project End
2013-05-31
Budget Start
2011-06-01
Budget End
2013-05-31
Support Year
15
Fiscal Year
2011
Total Cost
$345,150
Indirect Cost
Name
Stanford University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94305
Kiesler, Patricia; Haynes, Paul A; Shi, Lingfang et al. (2010) NF45 and NF90 regulate HS4-dependent interleukin-13 transcription in T cells. J Biol Chem 285:8256-67
Shi, Lingfang; Godfrey, Wayne R; Lin, Joseph et al. (2007) NF90 regulates inducible IL-2 gene expression in T cells. J Exp Med 204:971-7
Shi, Lingfang; Qiu, Daoming; Zhao, Guohua et al. (2007) Dynamic binding of Ku80, Ku70 and NF90 to the IL-2 promoter in vivo in activated T-cells. Nucleic Acids Res 35:2302-10
Zhao, Guohua; Shi, Lingfang; Qiu, Daoming et al. (2005) NF45/ILF2 tissue expression, promoter analysis, and interleukin-2 transactivating function. Exp Cell Res 305:312-23
Shi, Lingfang; Zhao, Guohua; Qiu, Daoming et al. (2005) NF90 regulates cell cycle exit and terminal myogenic differentiation by direct binding to the 3'-untranslated region of MyoD and p21WAF1/CIP1 mRNAs. J Biol Chem 280:18981-9
Graham, Kareem L; Thibault, Donna L; Steinman, Jonathan B et al. (2005) Granzyme B is dispensable for immunologic tolerance to self in a murine model of systemic lupus erythematosus. Arthritis Rheum 52:1684-93
Vaszar, Laszlo T; Nishimura, Toshihiko; Storey, John D et al. (2004) Longitudinal transcriptional analysis of developing neointimal vascular occlusion and pulmonary hypertension in rats. Physiol Genomics 17:150-6
Nishimura, Toshihiko; Vaszar, Laszlo T; Faul, John L et al. (2003) Simvastatin rescues rats from fatal pulmonary hypertension by inducing apoptosis of neointimal smooth muscle cells. Circulation 108:1640-5
Qiu, Daoming; Kao, Peter N (2003) Immunosuppressive and anti-inflammatory mechanisms of triptolide, the principal active diterpenoid from the Chinese medicinal herb Tripterygium wilfordii Hook. f. Drugs R D 4:1-18
Nishimura, Toshihiko; Faul, John L; Berry, Gerald J et al. (2002) Simvastatin attenuates smooth muscle neointimal proliferation and pulmonary hypertension in rats. Am J Respir Crit Care Med 166:1403-8

Showing the most recent 10 out of 20 publications